Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:11 am Sale |
2021-12-31 | 13G | 89bio, Inc. ETNB |
Nussbaum Ran | 827,701 4.100% |
-194,753 (-19.05%) |
Filing History |
| 2022-02-14 06:08 am Unchanged |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Nussbaum Ran | 44,643 4.960% |
0 (Unchanged) |
Filing History |
| 2021-02-16 11:16 am Sale |
2021-02-07 | 13G | ContextLogic Inc. LOGC |
Nussbaum Ran | 50,236 4.700% |
-4,333 (-7.94%) |
Filing History |
| 2021-02-16 07:31 am Purchase |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Nussbaum Ran | 44,643 6.400% |
44,643 (New Position) |
Filing History |
| 2021-02-11 08:52 am Sale |
2020-12-31 | 13G | ContextLogic Inc. LOGC |
Nussbaum Ran | 54,570 5.200% |
-5,279 (-8.82%) |
Filing History |
| 2021-02-09 10:20 am Sale |
2020-12-31 | 13G | 89bio, Inc. ETNB |
Nussbaum Ran | 1,022,454 5.100% |
-112,217 (-9.89%) |
Filing History |
| 2021-02-05 10:12 am Sale |
2020-12-31 | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV |
Nussbaum Ran | 219,306 1.300% |
-4,018,830 (-94.83%) |
Filing History |